Welcome to the European Society for Translational Antiviral Research

The European Society for translational Antiviral Research (ESAR) aims to unite scientists and clinicians throughout Europe to expand knowledge on resistant viruses and to investigate the molecular epidemiology of drug-resistant viruses in Europe from Public Health and scientific perspectives. ESAR will acts as a collaborative non-profit network for scientific studies, quality control, guidelines and training activities.

For more information about the Society please follow this link.


The Spring 2016 meeting of ESAR will take place on Tuesday May 24th in Rome. Visit the meeting page for more details and registration.
Recent publications

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CA, Schmit JC, Wensing AM; SPREAD Program. Clin Infect Dis. 2016 Mar 1;62(5):655-63.

The CAPRE study by the HEPVIR working group has been published in The Journal of Infectious Diseases August 15th.

An interesting article about the CAPRE study has been written by Reuters. Please find the article here.

Button SPREAD database   map

Button HepCare Database.JPG